Hypoxia-mimicking therapy to help recovery in inflammatory demyelinating disease
Official title: Evaluating the therapeutic potential of hypoxia mimetics in inflammatory demyelinating disease
Funded at San Diego Biomedical Research Institute · NIH-11352666 · Data updated 2026-11-12
Aims to see if drugs that mimic low-oxygen signals can speed recovery and reduce disability in conditions like multiple sclerosis by strengthening blood vessels and helping immune cells leave the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | San Diego Biomedical Research Institute NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project start | August 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $654,426 |
| NIH project number | 5R01NS138923-03 |
| Project ID | NIH-11352666 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults with inflammatory demyelinating disease or MS-like conditions who could participate in future trials or receive related therapies.
✕Less likely to help
Patients with non-inflammatory neurological conditions or those unable to participate in translational hypoxia-based approaches may not benefit.
What this research studies
This project tests drugs that activate the body’s low-oxygen response to promote healing in an animal model of multiple sclerosis. Researchers will identify a hypoxia-mimetic treatment plan that improves recovery from paralysis and reduces brain inflammation in disease models. The work looks at how these drugs remodel blood vessels in the brain and trigger the removal of inflammatory cells, potentially restoring the protective barrier and promoting remyelination. The study builds on prior findings that mild hypoxia can accelerate recovery and that hypoxia mimetics may reproduce these benefits. If successful, this could point toward new therapies to help people with MS-related nerve damage.
Why it matters
Potential benefit: Potentially faster recovery and less disability for people with inflammatory demyelinating diseases by improving brain barrier integrity and promoting repair.
How similar studies have gone: Previous work showed hypoxia-inspired strategies accelerated recovery in disease models, with improved vascular and remyelination markers; this builds on that approach in a refined protocol.
Where this research is happening
-
San Diego Biomedical Research Institute
San Diego, United States Active
Researchers
- Principal investigator: Milner, D. Richard — San Diego Biomedical Research Institute
- Study coordinator: Milner, D. Richard
Related research
Other NIH-funded projects on the same topics.
-
Using MRI to measure brain oxygen levels as an early sign of small vessel disease in the brain
This study is looking at how measuring oxygen levels in the brain with MRI can help spot early signs of small vessel disease, which is linked to memory problems and dementia, especially Alzheimer's, so if you're at risk due to age or high blood pressure, you might be able to participate in MRI scans to learn more about
-
HIF-driven ways to repair damaged lungs in IPF
A doctor-researcher is testing how low-oxygen signals (HIF) could help restore healthy lung tissue in people with IPF.
-
Neonatal Brain Injury Protection with New Purine Compounds
A new medication approach using purine derivatives is being studied to protect newborn brains from injury caused by limited blood flow and oxygen during birth.
-
Aldo-keto reductase (AKR) helps brain BH4 levels after injury
This grant tests whether brain AKR enzymes can boost BH4 levels and support better brain function after hypoxia-ischemia-related injury.
-
Dual-hypoxia and proliferation PET biomarker for recurrent glioblastoma
A study using a special PET imaging approach to map oxygen-poor areas and cell growth in recurrent brain tumors to guide treatment decisions.
-
How low oxygen and genetic tweaks may repair mitochondrial problems linked to Alzheimer’s and other disorders
A Johns Hopkins-style? (Note: institution specified later) patient-facing overview: researchers will study tiny cell power stations in mitochondria to see if low-oxygen conditions and specific genetic changes can fix problems associated with Alzheimer's disease and related dementias.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.